The Data Safety Monitoring Board completed the first interim analysis in January 2011 for the MSLT-II Clinical Trial.

› Forums › General Melanoma Community › The Data Safety Monitoring Board completed the first interim analysis in January 2011 for the MSLT-II Clinical Trial.

  • This topic is empty.
  • Post
    • May 22, 2014 at 5:17 pm
    1friend
    Participant

      Hey Group –

      Does anyone have a link or any information as to what the 'First Interim Analysis" of the MSLT-II clinical trial showed?

      Was complete lymph node dissection or monitor with ultra-sound showing the most promise?

       

      Thanks

    • You must be logged in to reply to this topic.
    About the MRF Patient Forum

    The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

    The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.